Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 27;50(27):6109-14.
doi: 10.1002/anie.201100884. Epub 2011 Apr 14.

Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells

Affiliations

Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells

Kejin Zhou et al. Angew Chem Int Ed Engl. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
a) Schematic design of pH-activatable micelle (pHAM) nanoprobes. At pH > pKa of ammonium groups (left panel), the neutralized PR segments self-assemble into the micelle cores, leading to quenching of fluorophores due to homoFRET and PeT mechanisms. Upon pH activation (pH < pKa, right panel), formation of charged ammonium groups results in micelle dissociation into unimers with dramatic increase in fluorescence emission. b) Structures of the PEO-b-(PR-r-TMR) copolymers in the di-alkyl and cyclic series.
Figure 2
Figure 2
Illustration of tunable, ultra-pH responsive properties of pHAM nanoprobes. a) Representative fluorescent images of different nanoprobe solutions (6, 3, 4) at the same polymer concentration (0.1 mg/mL) but different pH values. A narrow pH response is observed for each nanoprobe at different transition pHs. Copolymer 1 serves as an always “ON” control without pH response. A blue light (λex = 440 ~ 480 nm, 450 mW/cm2) was used to excite the nanoprobes. b) Normalized fluorescence intensity as a function of pH for different pHAM nanoprobes. The pH response (ΔpH10–90%) is <0.25 pH unit and Fmax/Fmin is up to 55-fold (Supplementary Table S2). c) Stopped flow fluorescence measurement of nanoprobe 4 (pHt = 5.4) after pH activation at 4.9. Fluorescence recovery time (τ1/2) is 3.7 ms. Other pHAM nanoprobes show similarly fast kinetics (Table S2).
Figure 3
Figure 3
Investigation of the ultra-pH responsive properties of a representative pHAM. a) pH titration curves of copolymers 5 and 7 and their corresponding monomers. The added volumes of NaOH (VNaOH) were normalized to the initial amount of amine residues ([R3N]0) in mmol. b) 1H NMR spectra (in D2O) of 5 and 7 at different ionization states of the copolymers. c) TEM of 7 in pH 5.5 and 7.4 buffers at the polymer concentration of 2 mg/mL.
Figure 4
Figure 4
Investigation of subcellular activation of nanoprobes 3 and 4 in different endocytic organelles in human H2009 cells. a, b) Representative confocal images of activated nanoprobe 3 (a, pHt = 6.3) and 4 (b, pHt = 5.4) in cells with GFP-labeled early endosomes (top panel) and late endosomes/lysosomes (bottom panel) at 30 and 45 min, respectively. c, d) Percentage of positive cells (N=30–50 cells) with activated nanoprobe 3 and 4 colocalizing with early endosomes or late endosomes/lysosomes at different incubation times, respectively. e, f) Schematic illustration of the selective activations of nanoprobe 3 in early endosomes (pH 5.9–6.2) and 4 in late endosomes/lysosomes (pH 5.0–5.5), respectively.
Figure 5
Figure 5
Inhibition of lysosomal acidification by bafilomycin A1 and its effect on intracellular activation of nanoprobe 3 in H2009 cells. a) Confocal images of cells treated with bafilomycin A1 for 1 h followed by nanoprobe 3 incubation for 1 h. Lack of activation of nanoprobe 3 was observed as demonstrated by the absence of TMR fluorescence. b) Confocal images of the same H2009 cells after removal of bafilomycin A1 and nanoprobe 3 and incubation for additional 5 h. Nanoprobe activation was observed as indicated by the red fluorescence inside lysosomes (yellow dots in the overlay images). Scale bar = 20 µm.

References

    1. Singhal S, Nie S, Wang MD. Annu. Rev. Med. 2010;61:359–373. - PMC - PubMed
    2. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Angew. Chem. Int. Ed. 2009;48:872–897. - PMC - PubMed
    3. Weissleder R, Pittet MJ. Nature. 2008;452:580–589. - PMC - PubMed
    4. Davis ME, Chen Z, Shin DM. Nat. Rev. Drug Discov. 2008;7:771–782. - PubMed
    5. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nat. Nanotech. 2007;2:751–760. - PubMed
    1. Torchilin V. Eur. J. Pharm. Biopharm. 2009;71:431–444. - PMC - PubMed
    2. Lee ES, Gao ZG, Bae YH. J. Controlled Release. 2008;132:164–170. - PMC - PubMed
    1. Lee ES, Na K, Bae YH. J. Controlled Release. 2003;91:103–113. - PubMed
    2. Bae Y, Fukushima S, Harada A, Kataoka K. Angew. Chem. Int. Ed. 2003;42:4640–4643. - PubMed
    3. Lynn DM, Amiji MM, Langer R. Angew. Chem. Int. Ed. 2001;40:1707–1710. - PubMed
    1. Choi SW, Zhang Y, Xia Y. Angew. Chem. Int. Ed. 2010;49:7904–7908. - PMC - PubMed
    2. Jeong B, Bae YH, Kim SW. J. Controlled Release. 2000;63:155–163. - PubMed
    1. Wang C, Chen Q, Wang Z, Zhang X. Angew. Chem. Int. Ed. 2010;49:8612–8615. - PubMed
    2. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY. Proc. Natl. Acad. Sci. USA. 2010;107:4311–4316. - PMC - PubMed
    3. Bernardos A, Aznar E, Marcos MD, Martínez-Máñez R, Sancenón F, Soto J, Barat JM, Amorós P. Angew. Chem. Int. Ed. 2009;48:5884–5887. - PubMed

Publication types

LinkOut - more resources